Specificities of septic complications prevention in elderly patients with concomitant diabetes mellitus undergoing major joint arthroplasty

Abstract

This article discusses the specificity of the perioperative period in patients with diabetes mellitus after major joint arthroplasty, and causes of an increased risk of septic complications development. The data on the criteria for compensating the course of diabetes mellitus when performing this operation were presented. Recommendations were given for the perioperative management of this category of patients in order to reduce the chance of developing wound and periprosthetic infections.

Keywords

review / arthroplasty / diabetes mellitus / septic complications / periprosthetic infection

References

[1] IDF Diabetes Atlas. 8th ed. 2017. Available at: http://www.diabetesatlas.org/

[2] Bonds DE, Larson JC, Schwartz AV, Strotmeyer ES, Robbins J, Rodriguez BL, et al. Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J. Clin. Endocrinol. Metab. 2006;91(9):3404-10. Doi: 10.1210/jc.2006-0614.

[3] Bonds D.E., Larson J.C., Schwartz A.V., Strotmeyer E.S., Robbins J., Rodriguez B.L., et al. Risk of fracture in women with type 2 diabetes: the Women’s Health Initiative Observational Study. J. Clin. Endocrinol. Metab. 2006;91(9):3404-10. Doi: 10.1210/jc.2006-0614.

[4] Schett G, Kleyer A, Perricone C., et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care. 2013;36(2):403-9. Doi: 10.2337/dc12-0924.

[5] Schett G., Kleyer A., Perricone C., et al. Diabetes is an independent predictor for severe osteoarthritis: results from a longitudinal cohort study. Diabetes Care. 2013;36(2):403-9; Doi: 10.2337/dc12-0924.

[6] Shohat N, Goswami K, Tarabichi M, Sahinbegovic E, Iagnocco A, Zwerina J, et al. All patients should be screened for diabetes before total joint arthroplasty. J. Arthroplasty. 2018;33(7):2057-61. Doi: 10.1016/j.arth.2018.02.047.

[7] Shohat N., Goswami K., Tarabichi M., Sahinbegovic E., Iagnocco A., Zwerina J., et al. All patients should be screened for diabetes before total joint arthroplasty. J. Arthroplasty. 2018;33(7):2057-61. Doi: 10.1016/j.arth.2018.02.047.

[8] Rudy MD, Ahuja NK, Aaronson AJ. Diabetes and hyperglycemia in lower-extremity total joint arthroplasty: clinical epidemiology, outcomes, and management. JBJS Rev. 2018;6(5):e10. Doi: 10.2106/JBJS.RVW.17.00146.

[9] Rudy M.D., Ahuja N.K., Aaronson A.J. Diabetes and hyperglycemia in lower-extremity total joint arthroplasty: clinical epidemiology, outcomes, and management. JBJS Rev. 2018;6(5):e10. Doi: 10.2106/JBJS.RVW.17.00146.

[10] Dedov II, Shestakova MV, Mayorov AYu, eds. Standards of specialized diabetes care. [Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol'nym sakharnym diabetom. Klinicheskie rekomendatsii]. 9th ed. Moscow; 2019. (in Russian) Doi: 10.14341/DM221S1.

[11] Дедов И.И., Шестакова М.В., Майоров А.Ю., ред. Алгоритмы специализированной медицинской помощи больным сахарным диабетом. Клинические рекомендации. 9-й вып. M.; 2019. Doi: 10.14341/DM221S1.

[12] Siu AL, US Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann. Intern. Med. 2015;163(11):861-8. Doi: 10.7326/M15-2345.

[13] Siu A.L.; US Preventive Services Task Force. Screening for abnormal blood glucose and type 2 diabetes mellitus: U.S. Preventive Services Task Force Recommendation Statement. Ann. Intern. Med. 2015;163(11):861-8. Doi: 10.7326/M15-2345.

[14] Reategui D, Sanchez-Etayo G, Nunez E, Tio M, Popescu D, Nunez M, Lozano L. Perioperative hyperglycaemia and incidence of post-operative complications in patients undergoing total knee arthroplasty. Knee Surg. Sports Traumatol. Arthrosc. 2015;23(7):2026-31. Doi: 10.1007/s00167-014-2907-7.

[15] Reategui D., Sanchez-Etayo G., Nunez E., Tio M., Popescu D., Nunez M., Lozano L. Perioperative hyperglycaemia and incidence of post-operative complications in patients undergoing total knee arthroplasty. Knee Surg. Sports Traumatol. Arthrosc. 2015;23(7):2026-31. Doi: 10.1007/s00167-014-2907-7.

[16] Kunutsor SK, Whitehouse MR, Blom AW, Beswick AD, INFORM Team. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150866. Doi: 10.1371/journal.pone.0150866.

[17] Kunutsor S.K., Whitehouse M.R., Blom A.W., Beswick A.D, INFORM Team. Patient-related risk factors for periprosthetic joint infection after total joint arthroplasty: a systematic review and meta-analysis. PLoS One. 2016;11(3):e0150866. Doi: 10.1371/journal.pone.0150866.

[18] Mor A, Berencsi K, Nielsen JS, Rungby J, Friborg S, Brandslund I, et al. Rates of community-based antibiotic prescriptions and hospital-treated infections in individuals with and without type 2 diabetes: a Danish Nationwide Cohort Study, 2004-2012. Clin. Infect. Dis. 2016;63(4):501-11. Doi: 10.1093/cid/ciw345.

[19] Mor A., Berencsi K., Nielsen J.S., Rungby J., Friborg S., Brandslund I., et al. Rates of community-based antibiotic prescriptions and hospital-treated infections in individuals with and without type 2 diabetes: a Danish Nationwide Cohort Study, 2004-2012. Clin. Infect. Dis. 2016;63(4):501-11. Doi: 10.1093/cid/ciw345.

[20] Iorio R, Williams KM, Marcantonio AJ, et al. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J. Arthroplasty. 2012;27(5):726-9.e1. Doi: 10.1016/j.arth.2011.09.013.

[21] Iorio R., Williams K.M., Marcantonio A.J., et al. Diabetes mellitus, hemoglobin A1C, and the incidence of total joint arthroplasty infection. J. Arthroplasty. 2012;27(5):726-9.e1. Doi: 10.1016/j.arth.2011.09.013.

[22] Shohat N, Parvizi J. Response to Letter to the Editor on "All patients should be screened for diabetes before total joint arthroplasty". J. Arthroplasty. 2019;34(4):814-5. Doi: 10.1016/j.arth.2018.11.036.

[23] Shohat N., Parvizi J. Response to Letter to the Editor on "All patients should be screened for diabetes before total joint arthroplasty". J. Arthroplasty. 2019;34(4):814-5. Doi: 10.1016/j.arth.2018.11.036.

[24] Uhl RL, Rosenbaum AJ, Dipreta JA, Desemone J, Mulligan M. Diabetes mellitus: musculoskeletal manifestations and perioperative considerations for the orthopaedic surgeon. J. Am. Acad. Orthop. Surg. 2014;22(3):183-92. Doi: 10.5435/JAAOS-22-03-183.

[25] Uhl R.L., Rosenbaum A.J., Dipreta J.A., Desemone J., Mulligan M. Diabetes mellitus: musculoskeletal manifestations and perioperative considerations for the orthopaedic surgeon. J. Am. Acad. Orthop. Surg. 2014;22(3):183-92. Doi: 10.5435/JAAOS-22-03-183.

[26] Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140-9. Doi: 10.2337/dc14-2441.

[27] Inzucchi S.E., Bergenstal R.M., Buse J.B., Diamant M., Ferrannini E., Nauck M., et al. Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care. 2015;38(1):140-9. Doi: 10.2337/dc14-2441.

[28] Buchleitner AM, Martínez-Alonso M, Hernández M, Solà I, Mauricio D. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst. Rev. 2012;(9):CD007315. Doi: 10.1002/14651858.CD007315.pub2.

[29] Buchleitner A.M., Martínez-Alonso M., Hernández M., Solà I., Mauricio D. Perioperative glycaemic control for diabetic patients undergoing surgery. Cochrane Database Syst. Rev. 2012;(9): CD007315. Doi: 10.1002/14651858.CD007315.pub2.

[30] Shohat N, Restrepo C, Allierezaie A, Tarabichi M, Goel R, Parvizi J. Increased postoperative glucose variability is associated with adverse outcomes following total joint arthroplasty. J. Bone Joint Surg. Am. 2018;100(13):1110-7. Doi: 10.2106/JBJS.17.00798.

[31] Shohat N., Restrepo C., Allierezaie A., Tarabichi M., Goel R., Parvizi J. Increased postoperative glucose variability is associated with adverse outcomes following total joint arthroplasty. J. Bone Joint Surg. Am. 2018;100(13):1110-7. Doi: 10.2106/JBJS.17.00798.

[32] Ceriello A, Esposito K, Piconi L, Ihnat MA, Thorpe JE, Testa R, et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349-54. Doi: 10.2337/db08-0063.

[33] Ceriello A., Esposito K., Piconi L., Ihnat M.A., Thorpe J.E., Testa R., et al. Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients. Diabetes. 2008;57(5):1349-54. Doi: 10.2337/db08-0063.

[34] Paneni F. 2013 ESC/EASD guidelines on the management of diabetes and cardiovascular disease: Established knowledge and evidence gaps. Diab. Vasc. Dis. Res. 2014;11:5-10. Doi: 10.1177/1479164113512859.

[35] Shohat N, Tarabichi M, Tischler EH, Jabbour S, Parvizi J. Serum fructosamine: a simple and inexpensive test for assessing preoperative glycemic control. J. Bone Joint Surg. Am. 2017;99(22):1900-7. Doi: 10.2106/JBJS.17.00075.

[36] Shohat N., Tarabichi M., Tischler E.H., Jabbour S., Parvizi J. Serum fructosamine: a simple and inexpensive test for assessing preoperative glycemic control. J. Bone Joint Surg. Am. 2017;99(22):1900-7. Doi: 10.2106/JBJS.17.00075.

[37] Burton LA, Sumukadas D. Optimal management of sarcopenia. Clin. Interv. Aging. 2010;5:217-28. Doi: 10.2147/cia.s11473.

[38] Burton L.A., Sumukadas D. Optimal management of sarcopenia. Clin. Interv. Aging. 2010;5:217-28. Doi: 10.2147/cia.s11473.

[39] Bremer JP, Jauch-Chara K, Hallschmid M, Schmid S, Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32(8):1513-7. Doi: 10.2337/dc09-0114.

[40] Bremer J.P., Jauch-Chara K., Hallschmid M., Schmid S., Schultes B. Hypoglycemia unawareness in older compared with middle-aged patients with type 2 diabetes. Diabetes Care. 2009;32(8):1513-7. Doi: 10.2337/dc09-0114.

[41] Bonds DE, Miller ME, Bergenstal RM, Buse JB, Byington RP, Cutler JA, et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909. Doi: 10.1136/bmj.b4909.

[42] Bonds D.E., Miller M.E., Bergenstal R.M., Buse J.B., Byington R.P., Cutler J.A., et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study. BMJ. 2010;340:b4909. Doi: 10.1136/bmj.b4909.

[43] Wong CW. Avoiding hypoglycaemia: a new target of care for elderly diabetic patients. Hong Kong Med. J. 2015;21(5):444-54. Doi: 10.12809/hkmj144494

[44] Wong C.W. Avoiding hypoglycaemia: a new target of care for elderly diabetic patients. Hong Kong Med. J. 2015;21(5):444-54. Doi: 10.12809/hkmj144494

[45] Singh JA, Lewallen DG. Diabetes: a risk factor for poor functional outcome after total knee arthroplasty. PLoS One. 2013;8(11):e78991. Doi: 10.1371/journal.pone.0078991.

[46] Singh J.A., Lewallen D.G. Diabetes: a risk factor for poor functional outcome after total knee arthroplasty. PLoS One. 2013;8(11):e78991. Doi: 10.1371/journal.pone.0078991.

RIGHTS & PERMISSIONS

Eco-Vector